Location permission needed for a better experience.
How can we help you?
CV
MEMBERSHIPS
PUBLICATIONS
EDUCATION
  • 1997 Dr. Siyami Ersek Göğüs, Kalp ve Damar Cerrahisi Eğitim ve Araştırma Hastanesi Kardiyoloji
  • 1992 İstanbul Üniversitesi İstanbul Tıp Fakültesi
EXPERIENCE
  • 2015 Acıbadem Sağlık Grubu
  • 2015 Acıbadem Üniversitesi Tıp Fakültesi
  • 2010 Acıbadem Sağlık Grubu
  • 2009 - 2010 Medicana International Hastanesi
  • 2006 - 2009 Şişli Florence Nightingale Hastanesi, Girişimsel Kardiyoloji Bölümü
  • 2005 - 2006 Çorlu Özel Şifa Hastanesi
  • 1998 - 2005 Kars Devlet Hastanesi
  • 1997 - 1998 Gümüşsuyu Asker Hastanesi
MEMBERSHIPS
  • Avrupa Perkütan Kardiyovasküler Girişimler Derneği
  • Avrupa Kalp Ritmi Birliği (EHRA)
  • Avrupa Kalp Yetmezliği Derneği
  • Türk Kardiyoloji Derneği
  • Avrupa Kardiyoloji Derneği Fellow (FESC), 2007
PUBLICATIONS
  • Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non- COVID-19 viral pneumonia Turk Kardiyoloji Dernegi Arsivi, 49(4), 286-292., Doi: 10.5543/tkda.2021.87750 GÖRMEZ SELÇUK, KIRISOGLU CEYDA EREL, EKICIBASI MEHMET ERKAN, DEGIRMENCIOGLU ALEKS, PAUDEL ASHOK, AKAN GÖKÇE, ATALAR FATMAHAN, SARIGÜZEL NEVIN,
  • Comparison of early and long-term follow-up results of percutaneous mitral balloon valvuloplasty and mitral valve replacement Revista da Associação Médica Brasileira, 67(1), 58-63., Doi: 10.1590/1806-9282.67.01.20200277 USTA EMRAH, ERDIM REFIK, GÖRMEZ SELÇUK, DOGAN ALI, EZELSOY MEHMET, KAHRAMAN SERKAN, BAYRAM MUHAMMED, YAZICIOGLU NURAN
  • Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-19. Bratislava Medical Journal-Bratislavske Lekarske Listy, 122(8), 582-589., Doi: 10.4149/BLL_2021_093 GÖRMEZ SELÇUK, KURTOGLU GÜMÜSEL HILAL, EKICIBASI MEHMET ERKAN, DEGIRMENCIOGLU ALEKS, PAUDEL ASHOK, G AKAN, ATALAR FATMAHAN, ERDIM REFIK, E EROGLU,
  • Association between renin-angiotensinaldosterone system inhibitor treatment, neutrophil-lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study Journal of Human Hypertension, 35(7), 588-597., Doi: 10.1038/s41371-020-00405-3 GÖRMEZ SELÇUK, EKICIBASI MEHMET ERKAN, DEGIRMENCIOGLU ALEKS, PAUDEL ASHOK, KURTOGLU GÜMÜSEL HILAL, E EROGLU, TANBOGA IBRAHIM HALIL, DAGDELEN SINAN,
  • Relationships between visceral/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome Cardiovascular Pathology, 46, 3-9., Doi: 10.1016/j.carpath.2019.107192 GÖRMEZ SELÇUK, ERDIM REFIK, AKAN GÖKÇE, ÇAYNAK BARIS, DURAN CIHAN, GÜNAY DEMET, SÖZER VOLKAN, ATALAR FATMAHAN
  • Mitral valve repair for ischemic mitral insufficiency an increased early postoperative risk for the elderly Turkish Journal of Thoracic and Cardiovascular Surgery, 23(2), 239-244., Doi: 10.5606/tgkdc.dergisi.2015.10645 ARITURK CEM,ÖKTEN EYÜP MURAT,GÜLLÜ AHMET ÜMIT,SENAY SAHIN,BUTURAK ALI,GÖRMEZ SELÇUK,TORAMAN FEVZI,KARABULUT ESREF HASAN,ALHAN HÜSEYIN CEM
  • Mediastinal adipose tissue expresses a pathogenic profile of 11-hydroxysteroid dehydrogenase Type 1 glucocorticoid receptor and CD68 in patients with coronary artery disease Cardiovascular Pathology, 22(3), 183-188., Doi: 10.1016/j.carpath.2012.07.006 ATALAR FATMAHAN,GÖRMEZ SELÇUK,ÇAYNAK BARIS,AKAN GÖKÇE,TANRIVERDI GAMZE,BILGIÇ GAZIOGLU SEMA,GÜNAY DEMET,DURAN CIHAN,BELHHAN AKPINAR,ÖZBEK UGUR,
  • The role of mediastinal adipose tissue 11-hydroxysteroid dehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease Cardiovascular Diabetology, 11(1), 115, Doi: 10.1186/1475-2840-11-115 ATALAR FATMAHAN,GÖRMEZ SELÇUK,ÇAYNAK BARIS,AKAN GÖKÇE,TANRIVERDI GAMZE,BILGIÇ GAZIOGLU SEMA,GÜNAY DEMET,DURAN CIHAN,AKPINAR BELHHAN,ÖZBEK UGUR,
  • Two Year Follow-up of Sirolimus Eluting Stents versus Paclitaxel Eluting Stents in Acute Myocardial Infarction. International Journal of Angiology, 21(01), 53-58., Doi: 10.1055/s-0032- 1302436 ERDIM REFIK,HELVACIOGLU FUNDA,GÖRMEZ SELÇUK,KANBER ÖCAL KARABAY,AYTEKIN VEDAT
  • Adipose Tissue Gene Expression of Adiponectin, Tumor Necrosis Factor and Leptin in Metabolic Syndrome Patients with Coronary Artery Disease Internal Medicine, 50(8), 805-810., Doi: 10.2169/internalmedicine.50.4753 GÖRMEZ SELÇUK,DEMIRKAN AYSE,ATALAR FATMAHAN,ÇAYNAK BARIS,ERDIM REFIK,SÖZER VOLKAN,GÜNAY DEMET,AKPINAR BELHHAN,ÖZBEK UGUR,BÜYÜKDEVRIM AHMET SEVIM

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP